A comparison of neurokinin 1 receptor knock-out (NK1-/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neuropharmacology

• Publication date

  2005-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NEUROPHARM.2004.12.016PMID 15814105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substance P Receptor Antagonists in Psychiatry

  2005cited by this paper
• The yohimbine-induced anticonflict effect in the rat, part II. Neurochemical findings

  2005cited by this paper
• Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice

  2004cited by this paper
• Increased basal noradrenaline (NA) efflux in the frontal cortex, and a modified behavioural response to the a2-adrenoceptor antagonist, atipamezole, in NK1 receptor knockout mice

  2004cited by this paper
• Investigation of the functional activity of alpha 2-adrenoceptors in NK1-/- and NK1+/+ mice

  2004cited by this paper
• Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.

  2004cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Substance P Acts through Local Circuits within the Rat Dorsal Raphe Nucleus to Alter Serotonergic Neuronal Activity

  2003cited by this paper
• Behavioral phenotyping of rodents.

  2003cited by this paper
• Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse.

  2003cited by this paper
• Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors.

  2003cited by this paper
• Differences in the mechanisms that increase noradrenaline efflux after administration of d‐amphetamine: a dual‐probe microdialysis study in rat frontal cortex and hypothalamus

  2003cited by this paper
• RX 821002 as a tool for physiological investigation of alpha(2)-adrenoceptors.

  2002cited by this paper
• Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.

  2002cited by this paper
• Modulation of brain stem monoamines and &ggr;-aminobutyric acid by NK1 receptors in rats

  2002cited by this paper
• Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).

  2002cited by this paper
• Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus

  2002cited by this paper
• Chronic substance P (NK1) receptor antagonist and conventional antidepressant treatment increases burst firing of monoamine neurones in the locus coeruleus.

  2002cited by this paper
• The Effects of General Anesthetics on Norepinephrine Release from Isolated Rat Cortical Nerve Terminals

  2002cited by this paper
• Neurokinins Activate Local Glutamatergic Inputs to Serotonergic Neurons of the Dorsal Raphe Nucleus

  2002cited by this paper
• Permissive role of neurokinin NK3 receptors in NK1 receptor‐mediated activation of the locus coeruleus revealed by SR 142801

  2002cited by this paper
• Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function.

  2001cited by this paper
• 5-Hydroxytryptamine (5-HT)1A Autoreceptor Adaptive Changes in Substance P (Neurokinin 1) Receptor Knock-Out Mice Mimic Antidepressant-Induced Desensitization

  2001cited by this paper
• Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei--potential implication for arousal and attention.

  2001cited by this paper
• Pharmacological blockade of brain alpha1-adrenoceptors as measured by ex vivo [3H]prazosin binding is correlated with behavioral immobility.

  2001cited by this paper
• Selective blockade of neurokinin (NK)1 receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats

  2001cited by this paper
• Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs

  2001cited by this paper
• A microdialysis study of the noradrenergic response in rat frontal cortex and hypothalamus to a conditioned cue for aversive, naturalistic environmental stimuli

  2000cited by this paper
• Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat.

  2000cited by this paper
• Effect of neurokinin‐1 receptor antagonists on the function of 5‐HT and noradrenaline neurons

  2000cited by this paper
• Rewarding effects of opiates are absent in mice lacking the receptor for substance P

  2000cited by this paper
• Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

  2000cited by this paper
• Effect of novel environmental stimuli on rat behaviour and central noradrenaline function measured by in vivo microdialysis

  1999cited by this paper
• Nanomolar concentrations of neuropeptides induce histamine release from peritoneal mast cells of a substrain of Wistar rats.

  1999cited by this paper
• Actions of α2 adrenoceptor ligands at α2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for α2A adrenoceptors

  1998cited by this paper
• Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

  1998cited by this paper
• Effect of RX 821002 at 5‐HT1A‐receptors in rabbit spinal cord in vivo

  1998cited by this paper
• The anxiogenic agents, yohimbine and FG 7142, disrupt the noradrenergic response to novelty.

  1998cited by this paper
• Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.

  1998cited by this paper
• Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5‐hydroxtryptamine system

  1997cited by this paper
• Prozac: panacea or puzzle?

  1996cited by this paper
• Alpha 2-adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections.

  1996cited by this paper
• Increased levels of extracellular noradrenaline in the frontal cortex of rats exposed to naturalistic environmental stimuli: modulation by acute systemic administration of diazepam or buspirone

  1996cited by this paper
• Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam.

  1995cited by this paper
• Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5‐hydroxytryptamine1A receptor activation

  1995cited by this paper
• Central noradrenergic neurones and stress.

  1995cited by this paper
• Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.

  1994cited by this paper
• Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.

  1994cited by this paper
• Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.

  1993cited by this paper
• Distribution of the substance P receptor (NK-1 receptor) in the central nervous system.

  1993cited by this paper
• Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats byα1 as compared toα2 agonists and antagonists

  1991cited by this paper
• Differential modulation of (+)-amphetamine-induced rotation in unilateral substantia nigra-lesioned rats by alpha 1 as compared to alpha 2 agonists and antagonists.

  1991cited by this paper
• A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.

  1990cited by this paper
• Hippocampal Noradrenaline and Serotonin Release over 24 Hours as Measured by the Dialysis Technique in Freely Moving Rats: Correlation to Behavioural Activity State, Effect of Handling and Tail‐Pinch

  1989cited by this paper
• The Design of Experiments.

  1989cited by this paper
• Phenylephrine-induced activity in mice as a model of central alpha 1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock.

  1984cited by this paper
• Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices.

  1983cited by this paper
• Substance P excitation of rat locus coeruleus neurones.

  1983cited by this paper
• Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists.

  1980cited by this paper
• Current concepts. II. New evidence for a locus coeruleus-norepinephrine connection with anxiety.

  1979cited by this paper

• Appraisal of the validity of preclinical investigations to predict the efficacy of psychedelic drugs as fast-acting antidepressants.

  2025cites this paper
• Rodent research of attention-deficit/hyperactivity disorder: insights into widely used animal models

  2025cites this paper
• Animal models of attention-deficit/hyperactivity disorder: Diversity and validity.

  2025cites this paper
• A Novel Rat Model of ADHD-like Hyperactivity/Impulsivity after Delayed Reward Has Selective Loss of Dopaminergic Neurons in the Right Ventral Tegmental Area

  2023cites this paper
• Rodent models of attention-deficit hyperactivity disorder: An updated framework for model validation and therapeutic drug discovery.

  2022cites this paper
• Animal Models of ADHD?

  2022cites this paper
• Visualization and Quantification of Neurokinin-1 receptors in Human Brain With Positron Emission Tomography

  2019cites this paper
• Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD)

  2017cites this paper
• Differences in the performance of NK1R−/− (‘knockout’) and wildtype mice in the 5‑Choice Continuous Performance Test

  2016cites this paper
• Perseveration by NK1R-/- (‘knockout’) mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test

  2016cites this paper
• The NK 1 R-/-mouse phenotype suggests that small body size , with a sex-and diet-dependent excess in body mass and fat , are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder

  2016cites this paper
• The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder

  2016cites this paper
• Perseveration by NK 1 R-/-( ‘ knockout ’ ) mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test

  2016cites this paper
• Targeting dynamic interplay among disordered domains or endophenotypes to understand complex neuropsychiatric disorders: Translational lessons from preclinical models.

  2015cites this paper
• Substance P excites GABAergic neurons in the mouse central amygdala through neurokinin 1 receptor activation.

  2015cites this paper
• A lack of functional NK1 receptors explains most, but not all, abnormal behaviours of NK1R-/- mice1

  2015cites this paper
• The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene ‘knockout’ mice: Sex differences and implications for the treatment of attention deficit hyperactivity disorder

  2015cites this paper
• Psychostimulants, antidepressants and neurokinin-1 receptor antagonists ('motor disinhibitors') have overlapping, but distinct, effects on monoamine transmission: the involvement of L-type Ca2+ channels and implications for the treatment of ADHD.

  2014cites this paper
• Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor ‘knockout’ mice

  2014cites this paper
• The behavioural response of mice lacking NK1 receptors to guanfacine resembles its clinical profile in treatment of ADHD

  2014influential citation
• The influence of test experience and NK1 receptor antagonists on the performance of NK1R-/- and wild type mice in the 5-Choice Serial Reaction-Time Task

  2014cites this paper
• Metabolic Syndrome, Alzheimer Disease, Schizophrenia, and Depression: Role for Leptin, Melatonin, Kynurenine Pathways, and Neuropeptides

  2013cites this paper
• Evaluation of the Neurokinin-1 receptor knockout mouse model of Attention Deficit Hyperactivity Disorder

  2013influential citation
• Antagonism of L-type Ca(v) channels with nifedipine differentially affects performance of wildtype and NK1R-/- mice in the 5-Choice Serial Reaction-Time Task.

  2013cites this paper
• Transgenic mouse models for ADHD

  2013cites this paper
• Rodent models of ADHD.

  2012cites this paper
• Increasing TNF levels solely in the rat hippocampus produces persistent pain‐like symptoms

  2012cites this paper
• Cortical nNOS neurons co-express the NK1 receptor and are depolarized by Substance P in multiple mammalian species

  2012cites this paper
• Adrenocortical and behavioural response to chronic restraint stress in neurokinin-1 receptor knockout mice.

  2012cites this paper
• Neurokinin-1 receptor deletion modulates behavioural and neurochemical alterations in an animal model of depression.

  2012cites this paper
• Somatostatin modulates generation of inspiratory rhythms and determines asphyxia survival.

  2012cites this paper
• Evidence for the differential co-localization of neurokinin-1 receptors with 5-HT receptor subtypes in rat forebrain

  2012cites this paper
• Performance Deficits of NK1 Receptor Knockout Mice in the 5-Choice Serial Reaction-Time Task: Effects of d-Amphetamine, Stress and Time of Day

  2011cites this paper
• The pharmacological properties of antidepressants

  2010cites this paper
• S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.

  2010cites this paper
• NK1 (TACR1) Receptor Gene ‘Knockout’ Mouse Phenotype Predicts Genetic Association with ADHD

  2010cites this paper
• Neurokinin1 Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological, and Behavioral Characterization

  2009cites this paper
• Tachykinin receptors as therapeutic targets in stress-related disorders.

  2009cites this paper
• Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder.

  2009influential citation
• Genetic background influences the behavioural and molecular consequences of neurokinin‐1 receptor knockout

  2008cites this paper
• Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactions.

  2008cites this paper
• The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs.

  2007cites this paper
• Substance P at the nexus of mind and body in chronic inflammation and affective disorders.

  2007cites this paper
• Genetic background influences the effect of neurokinin-1 receptor "knockout" in the mouse

  2007influential citation
• Disruption of noradrenergic transmission and the behavioural response to a novel environment in NK1R–/– mice

  2007cites this paper
• Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release

  2007cites this paper
• Effects of substance P on memory and mood in healthy male subjects

  2007cites this paper
• Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

  2006cites this paper
• Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review.

  2006cites this paper
• Chapter 6.3 The use of brain microdialysis in antidepressant drug research

  2006cites this paper
• Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.

  2006cites this paper
• Depressive behavior in mice due to immune stimulation is accompanied by reduced neural activity in brain regions involved in positively motivated behavior.

  2006cites this paper
• The role of substance P in stress and anxiety responses

  2006cites this paper
• Blockade of tachykinin NK1 receptors attenuates stress‐induced rise of extracellular noradrenaline and dopamine in the rat and gerbil medial prefrontal cortex

  2006cites this paper
• Investigation of a role for noradrenaline in the neurochemical and behavioural effects of an established and putative target for antianxiety/antidepressant drugs: a microdialysis and behavioural study in rats and NK1 receptor knockout mice.

  2005cites this paper